Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma	B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory	Recruiting	Early phase 1	2025-08-20		NCT07093411

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Hospital	101
Beijing GoBroad Hospital	42
First Affiliated Hospital of Wenzhou Medical University	117
Second Affiliated Hospital of Xi'an Jiaotong University	33
The Affiliated Hospital of Xuzhou Medical University	68
The First Affiliated Hospital of Zhengzhou University	203

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	4
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)	Hefei	China	3
The Second Affiliated Hospital of Xi'an Jiaotong University	Xi'an	China	22